CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth

Leuk Lymphoma. 1995 Jun;18(1-2):51-9. doi: 10.3109/10428199509064922.

Abstract

Members of the Tumour Necrosis Factor-Receptor (TNFR) family play an essential role in the control of lymphoid cell growth and differentiation. The ligand of one of its lymphoid-specific members, CD27, was recently characterized as CD70, a type II transmembrane molecule with homology to TNF that is expressed on activated T and B cells. Ligation of CD27 by its natural ligand generates a potent costimulatory signal for cytokine production and proliferation of activated T cells. In contrast to normal B cells, where CD27 expression is confined to germinal centre cells and to a small subset of circulating B lymphocytes, CD27 expression is found on a large array of distinct B-cell neoplasia. Here, we review recent data on the expression and function of TNFR family members on normal and malignant lymphocytes and propose a role for CD27-CD70 interaction in B-cell development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigens, CD*
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / pathology
  • CD27 Ligand
  • Cell Division / physiology
  • Humans
  • Leukemia, B-Cell / pathology*
  • Lymphoma, B-Cell / pathology*
  • Membrane Proteins / physiology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / physiology*

Substances

  • Antigens, CD
  • CD27 Ligand
  • CD70 protein, human
  • Membrane Proteins
  • Tumor Necrosis Factor Receptor Superfamily, Member 7